Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1802]
News [2707]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
ASCO 2013: Cetuximab superior to bevacizumab for advanced colorectal cancer
ASCO 2013: Cetuximab superior to bevacizumab for advanced colorectal cancer
ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye
ASCO 2013: New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye
Matrix metalloproteinase-8 induces interleukin expression in breast cancer cells
Matrix metalloproteinase-8 induces interleukin expression in breast cancer cells
Intensified, liposomal anthracycline-based chemo regimen for children with leukaemia may offer high survival rates without added heart toxicity
Intensified, liposomal anthracycline-based chemo regimen for children with leukaemia may offer high survival rates...
Beta-blockers may boost chemo effect in childhood cancer
Beta-blockers may boost chemo effect in childhood cancer
FDA approves erlotinib with EGFR mutation test for advanced NSCLC
FDA approves erlotinib with EGFR mutation test for advanced NSCLC
Chemo, radiation followed by surgery improves survival in lung cancer patients
Chemo, radiation followed by surgery improves survival in lung cancer patients
Mammograms reveal response to common cancer drug
Mammograms reveal response to common cancer drug
Gene signature can predict who will survive chemotherapy
Gene signature can predict who will survive chemotherapy
Key one marrow protein identified as potential new leukaemia treatment target
Key one marrow protein identified as potential new leukaemia treatment target

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation